EUVIMEDEUVIMED entdecken
Crossref

Factores pronósticos de remisión a largo plazo tras cirugía transesfenoidal en la enfermedad de Cushing

Pablo Abellán Galiana, Carmen Fajardo Montañana, Pedro Antonio Riesgo Suárez, José Gómez Vela, Carlos Meseguer Escrivá, Vicente Rovira Lillo

Endocrinología y Nutrición · 2013-10 · 60 (8) · 475-482

DOI: 10.1016/j.endonu.2012.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinología y Nutrición, 2013-10. Verfasst von Pablo Abellán Galiana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Diabetes, Hospital General de Castellón, Castellón de la Plana, Castellón, España. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is no consensus on the remission criteria for Cushing's disease or on the definition of disease recurrence after transsphenoidal surgery, and comparison of the different published series is therefore difficult. A long-term recurrence rate of Cushing's disease ranging from 2%-25% has been reported. Predictors of long-term remission reported include: 1) adenoma-related factors (aggressiveness, size, preoperative identification in MRI), 2) surgery-related factors, mainly neurosurgeon experience, 3) clinical factors, of which dependence on and duration of glucocorticoid treatment are most important, and 4) biochemical factors. Among the latter, low postoperative cortisol levels, less than 2 mcg/dL predict for disease remission. However, even when undetectable plasma cortisol levels are present, long-term recurrence may still occur and lifetime follow-up is required. We report the preliminary results of the first 20 patients with Cushing's disease operated on at our hospital using nadir cortisol levels less than 2 mcg/dl as remission criterion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ACTH-Secreting Pituitary AdenomaAdenomaAdolescentAdrenal InsufficiencyAdrenocorticotropic HormoneAdultCircadian RhythmCombined Modality TherapyDeamino Arginine VasopressinDexamethasoneFemaleFollow-Up StudiesGlucocorticoidsHormone Replacement TherapyHumansHydrocortisoneHypophysectomyMaleMetyraponeMiddle Aged

Stichwörter der Autor:innen

Cirugía transesfenoidalCortisolCortisol séricoCushing's diseaseEnfermedad de CushingFactores de remisiónRemission factorsTranssphenoidal surgery

Substanzen

GlucocorticoidsDexamethasoneAdrenocorticotropic HormoneDeamino Arginine VasopressinHydrocortisoneMetyrapone

Autor:innen und Institutionen

  • Unidad de Diabetes, Hospital General de Castellón, Castellón de la Plana, Castellón, España.

Zitieren

APA

Abellán Galiana, P., Fajardo Montañana, C., Riesgo Suárez, P. A., Gómez Vela, J., Escrivá, C. M., & Lillo, V. R. (2013). Factores pronósticos de remisión a largo plazo tras cirugía transesfenoidal en la enfermedad de Cushing. Endocrinología y Nutrición, 60(8), 475-482. https://doi.org/10.1016/j.endonu.2012.09.009

Vancouver

Abellán Galiana P, Fajardo Montañana C, Riesgo Suárez PA, Gómez Vela J, Escrivá CM, Lillo VR. Factores pronósticos de remisión a largo plazo tras cirugía transesfenoidal en la enfermedad de Cushing. Endocrinología y Nutrición. 2013;60(8):475-482. doi:10.1016/j.endonu.2012.09.009

BibTeX
@article{AbellnGaliana2013,
  author = {Abellán Galiana, Pablo and Fajardo Montañana, Carmen and Riesgo Suárez, Pedro Antonio and Gómez Vela, José and Escrivá, Carlos Meseguer and Lillo, Vicente Rovira},
  title = {Factores pronósticos de remisión a largo plazo tras cirugía transesfenoidal en la enfermedad de Cushing},
  journal = {Endocrinología y Nutrición},
  year = {2013},
  volume = {60},
  number = {8},
  pages = {475--482},
  doi = {10.1016/j.endonu.2012.09.009}
}
Kostenlos starten →